Latest News about REGN
Recent news which mentions REGN
2 Cheap Growth Stocks That Could Be Even Better Buys in November
October 15, 2021
From Motley Fool
90,000 U.S. adult deaths from COVID-19 over the summer could have been prevented if victims had been vaccinated, study finds
October 14, 2021
From MarketWatch
Pfizer Just Scored Another Key Regulatory Approval
October 14, 2021
From Motley Fool
3 Biotech Stocks You Can Buy and Hold for the Next Decade
October 13, 2021
From Motley Fool
AstraZeneca's COVID-19 Therapy Hits Goal In Phase 3 Trial
October 11, 2021
From Benzinga
Why Humana Is Suing Biogen
October 09, 2021
From Motley Fool
Regeneron Could Have a Big Catalyst Coming in 2022
October 09, 2021
From Motley Fool
Cramer Likes DraftKings, Skyworks, And These Automakers
October 07, 2021
From Benzinga
Is This The Turning Point for Inovio?
October 06, 2021
From Motley Fool
Tesla and Merck Give Investors Some Hope
October 04, 2021
From Benzinga
3 Stocks That Might Soar With Pills for COVID
October 03, 2021
From Motley Fool
Here Are the Leaders in the Race to Develop a COVID-19 Pill
October 03, 2021
From Motley Fool
From Benzinga
From MarketWatch
From Benzinga
Regeneron-Roche Post Encouraging New Data For COVID-19 Antibody Cocktail
September 30, 2021
From Benzinga
Why Shares of Editas Medicine Are Lower This Morning
September 29, 2021
From Motley Fool
7 Biotech Stocks Entering the Golden Boom Phase
September 28, 2021
From InvestorPlace
Graybug Vision Posts Six-Month Extension GB-102 Data Of Wet AMD Trial
September 28, 2021
From Benzinga
Will Moderna Stock Reach $500?
September 28, 2021
From Motley Fool
The Daily Biotech Pulse: Eisai, Biogen Pursue Approval Of Second Alzheimer's Treatment; Sanofi Changes mRNA Strategy; GSK Subsidiary To Develop Long-Acting HIV Preventive
September 28, 2021
From Benzinga
Breaking Down CRISPR Technology
September 28, 2021
From Motley Fool
3 Big Pharma Stocks Wall Street Thinks Could Soar By At Least 30%
September 28, 2021
From Motley Fool
Glaxo - Vir Biotech's COVID Treatment Approved In Japan
September 27, 2021
From Benzinga
Could AbbVie's New Collaboration Be a Blockbuster?
September 27, 2021
From Motley Fool
3 Top Biotech Stocks to Buy for the Long Haul
September 27, 2021
From Motley Fool
WHO Backs Regeneron COVID-19 Antibody Cocktail As It Calls For Equal Access
September 24, 2021
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.